Pfizer-BioNTech has entered late-stage clinical trials of their coronavirus vaccine in children between ages five and 11.

Just a few weeks after the shot was approved for teens ages 12 to 15 in the U.S., the companies are now testing safety and efficacy on younger children.

Join BJL on WhatsApp Status: Click here to Join BJL status for engagements, births, deals, levayos, events & more

Join BJL on WhatsApp Groups: Click here to Join an official BJL WhatsApp group for breaking news as it happens

Around 4,500 participants will be enrolled at nearly 100 clinical trial sites in 26 states, Finland, Poland and Spain, according to a press release.

Read more at Daily Mail.